Shop
Showing 1–16 of 81 results
-
LARODX Larotrectinib
Larotrectinib is a potent, oral, selective tropomyosin receptor kinase (TRK) inhibitor …Select options This product has multiple variants. The options may be chosen on the product page -
OLADX Olaparib
Olaparib is a poly(ADP-polysaccharide) polymerase (PARP) inhibitor that was approved by…Select options This product has multiple variants. The options may be chosen on the product page -
PRASEDX Pralsetinib
Pralsetinib is an oral, once-daily RET (Rearranged during Transfection) receptor tyrosi…Select options This product has multiple variants. The options may be chosen on the product page -
OYSIENDX Osimertinib 80mg
Osimertinib is a third-generation irreversible epidermal growth factor receptor (EGFR) …Select options This product has multiple variants. The options may be chosen on the product page -
REPODX Repotrectinib
Repotrectinib is a next-generation tyrosine kinase inhibitor that targets the ROS1 and …Select options This product has multiple variants. The options may be chosen on the product page -
BESIDX Abemaciclib
Abemaciclib is a selective CDK4 and CDK6 inhibitor used to treat advanced or metastatic…Select options This product has multiple variants. The options may be chosen on the product page -
KESODX Crizotinib
Crizotinib is an ALK and ROS1 inhibitor used to treat non-small cell lung cancer. Crizo…Select options This product has multiple variants. The options may be chosen on the product page -
Mobocertinib Capsules (MOBODX) 40mg – Buy Online
The U.S. FDA has granted accelerated approval to mobotinib for the treatment of adult p…Select options This product has multiple variants. The options may be chosen on the product page -
AIVODX Ivosidenib 250mg
Ivosidenib is the world's first approved IDH1 inhibitor. In July 2018, Ivosidenib was a…Select options This product has multiple variants. The options may be chosen on the product page -
ENTREDX Entrectinib 200mg
Entrectinib is an inhibitor of tropomyosin receptor tyrosine kinase (TRK) TRKA, TRKB, T…Select options This product has multiple variants. The options may be chosen on the product page -
WELIDX Belzutifan
Belzutifan is a HIF-2α inhibitor. HIF, or hypoxia-inducible factor, is a key oncogenic …Select options This product has multiple variants. The options may be chosen on the product page -
TUKADX Tucatinib 150mg
Tucatinib is a small-molecule oral tyrosine kinase inhibitor (TKI) that was approved fo…Select options This product has multiple variants. The options may be chosen on the product page -
SEPADX Selpercatinib 40mg
On May 8, 2020, the U.S. Food and Drug Administration (FDA) approved selpercatinib, the…Select options This product has multiple variants. The options may be chosen on the product page -
TRAMEDX Trametinib 2mg
Trametinib is a MEK inhibitor with anticancer activity, inhibiting MEK1 and MEK2. It wa…Select options This product has multiple variants. The options may be chosen on the product page -
LORLADX Lorlatinib 100mg
Lorlatinib is a third-generation drug for the treatment of non-small cell lung cancer (…Select options This product has multiple variants. The options may be chosen on the product page -
VEMUDX vemurafenib
Vemurafenib induces programmed apoptosis in melanoma cell lines. If B-Raf has the commo…Select options This product has multiple variants. The options may be chosen on the product page
